A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
MigraineCommon Migraine2 moreThe purpose of this study is to evaluate the safety and efficacy of three doses of topiramate (50 milligrams[mg], 100mg, and 200mg per day) compared with placebo in the prevention of migraine. The study will also assess the dose response relationship and the efficacy of treatment with topiramate versus placebo on Health-Related Quality of Life.
Propofol Injection for Daily Headache
Chronic HeadacheAnalgesic Rebound Headache3 moreHypothesis A single subanesthetic dose of propofol will result in improved pain and quality of life for the next 30 days in persons with chronic daily headache (CDH) Specific objectives To measure the effect of a single infusion of propofol at 40 mcg / kg / minute over 60 mins on headache-related quality of life (measured by the Headache Disability Index) and on headache severity (measured by the Headache Index) in subjects with chronic daily headache over 30 days45-47
A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in...
MigraineVascular HeadachesThe primary purpose of this study is to evaluate the effectiveness and safety of topiramate compared with placebo in the prevention of migraine attacks in children (12 to 17 years of age).
Prophylactic Treatment of Episodic Cluster Headache
Cluster HeadacheThe purpose of this study is to determine whether candesartan cilexetil are effective prophylactic treatment of episodic Cluster headache
A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster...
Episodic Cluster HeadacheThis is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment...
MigraineMigraines are a specific type of headache that frequently recur and are very painful. Although there are many medications that are effective against migraines, none of these medications cure 100% of migraines. Another problem with migraines is that although many times they get better after intravenous (IV) treatment in the emergency room (ER), about 1/3 of the time migraines recur the next day. The purpose of this research project is to see if adding a medication called dexamethasone to standard ER therapy will help patients get better quicker and stay pain-free more often than if they receive placebo.
Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
HeadacheThe purpose of this study is to determine whether prednisolone is more effective than placebo in the first six days after initiation of medication withdrawal therapy for a medication overuse headache. Another purpose is to study whether patients followed by a neurologist 1 year after withdrawal do better than patients followed by a general practitioner.
Dry Needle In Management of Cervicogenic Headache
Cervicogenic HeadacheHeadache is an important health problem. It is the commonest type of all signs of illness in the people worldwide. Cervicogenic Headache is commonest musculoskeletal condition in physiotherapy practice. This study's main objective was to evaluate effectiveness of Dry Needle with exercise in decreasing pain and improving function in patients with Cervicogenic Headache.
Nebulized Dexmedetomidine Versus Neostigmine/Atropine in Postdural Puncture Headache
Postdural Puncture HeadacheIn our study, we will compare a new route of nebulization for effectiveness between dexmedetomidine, neostigmine/atropine and saline placebo for females complained of postdural puncture headache (PDPH) after cesarean section.
Feasibility of Using Holographic Memory Resolution® (HMR) in Patients/Clients With Pain
Chronic PainHeadache3 moreStudy Purpose: This study will explore the feasibility of administering Holographic Memory Resolution® (HMR) to adults who are experiencing chronic pain for 6 months or more.